Acorda Therapeutics reported $7.56M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Acorda Therapeutics ACOR:US $ 7.56M 0.22M
Amgen AMGN:US $ 295M 40M
Biogen BIIB:US $ 66.1M 0.2M
Biomarin Pharmaceutical BMRN:US $ 3.81M 0.04M
Clovis Oncology CLVS:US $ 9.1M 0.59M
Cytokinetics CYTK:US $ 2.75M 1.47M
Gilead Sciences GILD:US $ 238M 0M
Halozyme Therapeutics HALO:US $ 1.76M 0.3M
Insmed INSM:US $ 3.29M 8.06M
Ligand Pharmaceuticals LGND:US $ 0.79M 3.68M
Mannkind MNKD:US $ 5.12M 0.98M
Moderna Inc MRNA:US 6M 0
Neurocrine Biosciences NBIX:US $ 2.6M 4M
Novartis NOVN:VX 201M 5M
Pfizer PFE:US $ 322M 6M
Teva Pharmaceutical TEVA:IT 238M 58M
Vertex Pharmaceuticals VRTX:US $ 14.9M 0.19M